Baltic School of Neuro-Myology
Neuromuscular Junction Disorders: Bridging Research, Diagnosis, and Treatment
22-23 August 2025 | Jurmala, Latvia
About the Baltic School
It is our pleasure to announce the 5th Baltic School of Neuro-Myology: Bridging Research, Diagnosis, and Treatment that will take place on 22-23 August 2025 in Jurmala, Latvia. The official language of the event will be English. This meeting is endorsed by the ERN EURO-NMD.
The 5th Baltic School of Neuro-Myology: Bridging Research, Diagnosis, and Treatment is intended for neurologists, child neurologist, geneticists, pathologists, pulmonologists, orthopedists, other speciality doctors, physiotherapists, nurses.
The first Baltic School of Neuro-Myology “Metabolic Muscle Disorders”, took place in Riga, Latvia, April 26th-27th 2019 thanks to the organizing committee from France and Sweden. This is the beginning of a new tradition on neuromuscular disorders events. The school was attended by established and young physicians, researchers, therapists and neuropathologists from the Baltic states and Europe. This event invited everyone interested in neuromuscular disorders to increase their knowledge and share experience in all aspects of this issue.
The second Baltic School of Neuro-Myology “Limb-girdle muscular dystrophies”, took place in Riga, Latvia, August 26th-27th 2022. The school was attended by specialists from all over the Europe – Latvia, Estonia, Lithuania, Finland, France, Sweden and Italy.
Conference premises
Lielupe Hotel by Semarah
Bulduru Avenue 64/68
Jurmala, LV-2010, Latvia
website
We are here to help
In the case of questions feel free to contact us via email info@infinityevents.lv
PROGRAMME
Welcome Coffee & Registration
Opening Remarks: Shaping the Future of Neuromuscular Research
Lecture: Neuromuscular Junction Physiology – A Gateway to Understanding Disorders
Chairs: TBA
Prof. Csilla Rosca, HungaryLecture: Myasthenia Gravis – Strategies for Accurate Diagnosis
Coffee Break & Networking
Lecture: MuSK-Positive Myasthenia Gravis – Clinical Features and Latvian Experience
Lecture: MG Crisis Management – Emergency Response and Best Practices
Lunch Break
Interactive Workshop: Mastering Electromyography – Techniques and Pitfalls
Afternoon Coffee Break
Lecture: Myasthenia Gravis Management – From Treatment to Prognosis
Lecture: Multidisciplinary Approach in Myasthenia Gravis – Optimizing Patient Care
Case Study Panel: Real-Life Diagnostic Dilemmas in MG
Lecture: Neuromuscular Junction Disorders in Lithuania
Lecture: Neuromuscular Junction Disorders in Latvia
Chairs: TBA
Dr. Arta Grosmane/Assoc. Prof. Viktorija Kenina, LatviaLecture: Neuromuscular Junction Disorders in Estonia
Coffee Break & Networking
Lecture: Historical landmarks of the CMS saga
Lecture: Common Congenital Myasthenic Syndromes – Red Flags and Diagnosis
Lecture: Clinical Management: Best Practices for Complex Cases Speaker
Lunch Break
Lecture: Lambert-Eaton Myasthenic Syndrome – Identifying Key Clinical Features
Lecture: Lambert-Eaton Myasthenic Syndrome – Evidence-Based Treatment Approaches
Closing Remarks: Advancing Collaboration in Neuromuscular Junction Disorders
Organizing committee
Meet our distinguished team
Lecturers
BJARNE UDD
Prof., MD, PhD
Neuromuscular Research Center, University of Tampere
Folkhälsan Institute of Genetics, Biomedicum, University of Helsinki
Dr. Bjarne Udd was born in Finland and received his MD from the University of Berne, Switzerland, in 1975. He completed his residency in Neurology at the University Hospital in Umeå, Sweden, and the University Hospital in Helsinki, Finland.
In 1992, he earned his PhD from Helsinki University with a thesis on a newly identified type of muscular dystrophy, which leads to distal Tibial muscular dystrophy (TMD) in heterozygotes and severe LGMD2J in homozygous patients.
Dr. Udd has held an academic appointment (Docent) at Tampere University since 1997. In 2004, he became the Head of the Advanced Neuromuscular Diagnostics Program at Tampere University Hospital, a nationwide and international quaternary referral center for neuromuscular disease patients with undetermined diagnoses. In 2008, he was appointed Professor of Neurology in Neuromuscular Disorders, and in 2013, the clinical service was expanded into the Neuromuscular Research Center at Tampere University Hospital.
Currently, Dr. Udd leads two research groups:
- One at the Folkhälsan Research Center in Helsinki
- One at Tampere University Hospital
He is an active member of several international research boards in neuromuscular diseases. His research primarily focuses on very rare neuromuscular diseases, including:
- Muscular dystrophies
- Distal myopathies
- Rimmed vacuolar myopathies
- Limb-girdle dystrophies
- Myotonic dystrophy type 2
Dr. Udd was the first to describe a human muscle disease caused by titin mutations, including TMD (Udd myopathy) and LGMD2J. His research has contributed to the identification of over 20 new muscle diseases, many involving previously unknown myopathy genes.
Dr. AMIR DORI
Senior Clinical Lecturer of Neurology, Tel-Aviv University
Director, Neuromuscular Clinic & Neuromuscular Pathology and Research Lab, Sheba Medical Center, Israel
Dr. Amir Dori earned his MD and PhD from Ben-Gurion University Medical School in Israel and is board-certified in neurology. Following a three-year neuromuscular clinical fellowship at Washington University in St. Louis, he returned to Israel in 2014 and established the Sheba Neuromuscular Clinic and Neuromuscular Pathology and Research Lab.
Dr. Dori’s research focuses on neuromuscular disorders, including:
- ALS (Amyotrophic Lateral Sclerosis)
- Hereditary amyloidosis
- Immune-mediated polyneuropathy
- Ultrasound imaging of neuromuscular disorders
He integrates human tissue biopsy samples into basic science research, contributing to advancements in the field. He has published over 50 peer-reviewed papers and has received multiple awards for excellence.
Currently, Dr. Dori serves as a senior clinical lecturer of neurology at Tel-Aviv University and is the director of the Neuromuscular Clinic, Neuromuscular Pathology, and Research Lab at Sheba Medical Center.
